Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed Quote. Delayed London Stock Exchange - 01/27 11:35:15 am
8836 GBX   +4.19%
11:09aEuropean ADRs Move Higher in Thursday Trading
MT
07:50aSAP to buy U.S. fintech Taulia; eyes metaverse opportunities
RE
01/25Valneva Includes Booster Shots in Late-Stage Study of COVID-19 Jab
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca Explores Listing of Newly-Created Vaccines Unit

12/03/2021 | 03:26pm EST


ę MT Newswires 2021
All news about ASTRAZENECA PLC
11:09aEuropean ADRs Move Higher in Thursday Trading
MT
07:50aSAP to buy U.S. fintech Taulia; eyes metaverse opportunities
RE
01/25Valneva Includes Booster Shots in Late-Stage Study of COVID-19 Jab
MT
01/25Valneva Starts Extended Trial to Study Booster Shot of COVID-19 Vaccine; Shares Up 9%
MT
01/25Orange Corners South Africa and AstraZeneca South Africa join forces in a new partnersh..
AQ
01/25Germany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1
RE
01/25Orange Corners South Africa and AstraZeneca South Africa join forces in a new partnersh..
AQ
01/25Egetis appoints Karl Hård as Head of Investor Relations and Communication
AQ
01/24PCI Biotech Loses 10% As It Discontinues Cancer Trial To Focus On Immunotherapies
MT
01/24AstraZeneca's Rare Progressive Disease Drug Granted US FDA Orphan Drug Tag
MT
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 36 228 M - -
Net income 2021 2 276 M - -
Net Debt 2021 24 734 M - -
P/E ratio 2021 59,4x
Yield 2021 2,37%
Capitalization 183 B 183 B -
EV / Sales 2021 5,74x
EV / Sales 2022 4,72x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 118,29 $
Average target price 139,09 $
Spread / Average Target 17,6%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC1.82%177 586
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642